REVIEW
|
doi:10.20944/preprints202103.0262.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
immune checkpoint inhibitors; immune checkpoint radiolabeled antibodies; PD-1; PD-L1; immune PET; immunotherapy; AI; Radiomics; Deep learning; CAR-T cells
Online: 9 March 2021 (11:12:55 CET)
REVIEW
|
doi:10.20944/preprints202108.0372.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitors; non-small cell lung carcinoma; PD-1; PD-L1; immune PET; immunotherapy; Radiomics; PET/CT
Online: 18 August 2021 (08:20:43 CEST)
REVIEW
|
doi:10.20944/preprints202011.0445.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Peptide Receptor Radionuclide Therapy; PRRT; 68Ga-labeled somatostatin analogue; 18F-FDG; response assessment; RECIST; SWOG; WHO; neuroendocrine tumors; NET
Online: 17 November 2020 (10:35:21 CET)
REVIEW
|
doi:10.20944/preprints202306.0677.v1
Subject:
Public Health And Healthcare,
Other
Keywords:
neuroendocrine tumor; NET; machine-learning; nuclear medicine; theragnostics; PET; DOTA PET; radiomics
Online: 9 June 2023 (07:04:06 CEST)
REVIEW
|
doi:10.20944/preprints202305.0801.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immunotherapy; lung cancer; PET; response to therapy; PD-L1
Online: 11 May 2023 (05:32:06 CEST)
ARTICLE
|
doi:10.20944/preprints202110.0145.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitors; PD-1; PD-L1; CTLA-4; immunotherapy; target therapy; BRAF; MET; melanoma; [18F]FDG PET/CT
Online: 8 October 2021 (14:14:14 CEST)